Get the Daily Brief
Latest Biotech News
LaNova Medicines acquired by Sino Biopharmaceutical for nearly $951 million
China-based Sino Biopharmaceutical has completed the acquisition of the remaining 95.09% stake in LaNova Medicines, valuing the deal at approximately $951 million, including the cash and deposits...
Breakthrough research in plant molecular biology and genomics
Recent studies have advanced understanding of gene regulation and systemic signaling in plants, including a mobile transcription factor coordinating nitrogen deficiency responses across plant...
Micro-CT Scans May Damage Fossil Integrity
A new study published in Radiocarbon reveals that micro-computerized tomography (micro-CT), a widely used technique believed to be non-destructive, may actually impact the preservation of fossils....
Miniaturized Bioreactors Employ Magnetic Levitation Stirring
At the Bioprocess Engineering 2025 meeting in Bremen, researchers from Zurich University of Applied Sciences and Levitronix presented a novel benchtop bioreactor that uses magnetic levitation for...
Cell-Free Therapies Offer Scalable Heart Attack Treatment Alternatives
Researchers highlight the manufacturing challenges that impede cell therapies for heart attack and propose 'cell-free' approaches using proteins and secretomes as easier-to-make alternatives....
Advances in Digital Twins Enhance Biomanufacturing Process Control
A team led by Dr. Moo Sun Hong at Seoul National University is optimizing digital twin models for end-to-end biomanufacturing by leveraging eight years of data sets collected originally at MIT....
Agentic AI to Revolutionize Autonomous Biomanufacturing Control
Researchers from the Technical University of Denmark and industry partners, including Novo Nordisk and SiC Systems, have developed an integrated agentic AI platform called SIC that autonomously...
Johnson & Johnson Posts $15B Pharma Sales, Offsets Stelara Losses
Johnson & Johnson reported $15.2 billion in Q2 pharmaceutical sales, surpassing $15 billion for the first time despite a 43% decline in Stelara revenue due to biosimilar competition. Growth in...
FDA Overrules Modena Reviewers, Narrows COVID-19 Shot Approval in Kids
Vinay Prasad, head of the FDA’s vaccine regulation office, overruled agency reviewers to narrowly approve Moderna’s Spikevax COVID-19 vaccine only for children aged 6 months to 11 years at...
Nuclidium Secures $98M Series B to Advance Copper-Based Radiotheranostics
Swiss-German radiopharmaceutical firm Nuclidium raised $98 million in a Series B round led by Kurma Growth Opportunities Fund and other investors. The funding supports clinical development and...
FDA Flags Safety Concerns as GSK Seeks Blenrep’s Return in Multiple Myeloma
Ahead of the FDA Oncologic Drugs Advisory Committee meeting, regulators released briefing documents raising concerns over GSK’s antibody-drug conjugate Blenrep's ocular toxicity and uncertain safe...
Merck Acquires Verona Pharma to Boost Ohtuvayre COPD Sales and Patent Protection
Merck & Co. finalized its $10 billion acquisition of Verona Pharma, gaining the respiratory drug Ohtuvayre approved in 2024 for chronic obstructive pulmonary disease. Despite the original...
Kenvue CEO Out, Strategic Review Underway Amid Sales Decline
Kenvue, the consumer health spinout from Johnson & Johnson, has initiated a CEO transition with Thibaut Mongon stepping down and board member Kirk Perry appointed interim CEO. This leadership...
France's Perigenomed Project Advances Genome Sequencing for Newborns
The Perigenomed initiative in France is pioneering routine genome sequencing-based newborn screening to detect hundreds of treatable rare diseases before symptoms emerge. CHU Dijon has sequenced...
Broad State Participation in Medicaid Sickle Cell Gene Therapy Program
Approximately 33 states representing 84% of Medicaid beneficiaries have adopted a Centers for Medicare & Medicaid Services (CMS) program enabling pay-for-performance arrangements with gene therapy...
Genetic Alliance Expands Rare Disease Genomic Testing via $500K Grant
Genetic Alliance has secured a $500,000 grant from the Helmsley Charitable Trust to broaden its iHope Rare Disease program, which offers free whole-genome and exome sequencing for underserved...
ABL Diagnostics Partners for Molecular Assay Distribution in South Africa
ABL Diagnostics entered a commercialization agreement with Anatech Instruments to market its DeepChek and UltraGene molecular assay lines in South Africa. Anatech will offer DeepChek’s sequencing...
Ultragenyx Gene Therapy for Sanfilippo Syndrome Faces FDA Manufacturing Rejection
The FDA issued a complete response letter rejecting Ultragenyx’s gene therapy UX111 for Sanfilippo syndrome type IIIA, citing manufacturing process deficiencies identified during facility...
ABB AstraZeneca’s Phase III Win with Baxdrostat in Resistant Hypertension
AstraZeneca announced positive results from its BaxHTN phase III trial where baxdrostat, an aldosterone synthase inhibitor, achieved primary and secondary endpoints in patients with uncontrolled...
Hengrui and Kailera Advance Dual-Acting Obesity Drug with Chinese Phase III Success
Hengrui Pharmaceuticals and Kailera Therapeutics reported strong Phase III efficacy for their injectable GLP-1/GIP dual receptor agonist in China, showing approximately 18% mean weight loss over...